Test Price
2,000 AED✅ Home Collection Available
ALL FISH Panel (Acute Lymphoblastic Leukemia) in UAE | 2,000 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation provided by a Specialist Team.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ALL FISH Panel is a targeted molecular cytogenetic test that detects four critical chromosomal rearrangements (BCR::ABL1, ETV6::RUNX1, KMT2A, and TCF3) in patients with suspected or confirmed acute lymphoblastic leukemia, guiding precise diagnosis, risk stratification, and therapy selection. Interphase Fluorescence In-Situ Hybridization (FISH) is used for sub‑microscopic detection with >99% analytical sensitivity.
| Feature | Our ALL FISH Panel | Conventional Karyotyping |
|---|---|---|
| Precision & Resolution | Sub‑microscopic rearrangements; >99% analytical sensitivity | Limited to >5 Mb aberrations; requires dividing cells |
| Methodology | Interphase Fluorescence In‑Situ Hybridization (FISH) | Giemsa‑banding chromosome analysis |
| Turnaround Time | 10 calendar days | 14–21 days (culture‑dependent) |
| Clinical Utility | Definitive risk‑group assignment; MRD monitoring | Genome‑wide screen; lower resolution |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I emphasize that the ALL FISH Panel provides submicroscopic chromosomal data essential for risk stratification. However, all results must be integrated with morphology, immunophenotype, and clinical presentation. Treatment decisions should never be made solely on FISH findings without multidisciplinary consultation. — Lina Osama Zaki Quteineh (DHA Registration ID: 9294403)”
Medication Advisory
⚠ Medication Warning
Do not discontinue prescribed medication or modify your treatment plan without consulting your treating physician.
Safety and Appropriateness
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: This test is not indicated for asymptomatic individuals or general health screening. It is intended only for patients with a clinical suspicion or confirmed diagnosis of acute leukemia. Sample collection is not performed on patients with active severe coagulopathy unless corrected.
- Emergency Red Flags: If you experience sudden high fever with rigors, uncontrolled bleeding, new neurological symptoms, or severe shortness of breath, seek immediate emergency care and inform the ER team that you are undergoing leukemia evaluation.
Required Prescription & Sample Logistics
- A valid physician’s prescription is required for this panel. Exceptions: surgical clearance mandated by a hospital, pregnancy‑related emergencies, and pre‑travel regulatory medical reports – in these cases appropriate statutory documentation may replace the prescription.
- Sample type: Bone marrow aspirate (preferred) or peripheral blood. Specimen must be collected in a heparinised syringe (bone marrow) or EDTA tube (peripheral blood) and transported immediately at room temperature. Delayed transport beyond 2 hours may compromise cell viability and result accuracy.
- No fasting or medication avoidance is required solely for the FISH procedure, but follow your doctor’s specific preparation instructions.
Patient FAQ & Clinical Guidance
1. Why is the ALL FISH Panel important for my diagnosis?
Snippet: This panel identifies four key chromosomal translocations that classify acute lymphoblastic leukemia into risk groups and guide precise therapy.
The ALL FISH Panel detects BCR::ABL1, ETV6::RUNX1, KMT2A, and TCF3 rearrangements, each with distinct prognostic significance. For example, ETV6::RUNX1 typically indicates a favourable outcome in children, while KMT2A rearrangement confers high risk. The results help your haematologist‑oncologist choose the most effective chemotherapy or targeted agent.
2. Can this be performed on a simple blood draw instead of bone marrow?
Snippet: While peripheral blood can be used when circulating blasts are high, bone marrow aspirate remains the gold standard for diagnostic accuracy.
In many cases of ALL, leukaemic cells spill into the bloodstream, allowing FISH analysis on peripheral blood. However, if the percentage of abnormal cells is low, a bone marrow sample yields more reliable results. Your physician will determine the most appropriate sample type based on your complete blood count and blast percentage.
3. How soon will I receive my results and who interprets them?
Snippet: The standard turnaround time is 10 working days, and a board‑certified molecular pathologist provides the final signed report with interpretive comments.
Our laboratory adheres to strict quality controls with dual‑review of FISH signals. Once the report is issued, you will have access to a telephonic consultation where a clinical specialist explains the findings in the context of your overall diagnosis. All reports are transmitted securely via encrypted email or the patient portal.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All processing is performed under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited laboratory standards. For insurance pre‑authorisation or appointment scheduling, contact +971 54 548 8731 (WhatsApp available).
Clinical & Logistical Metadata
| Test Name | ALL FISH Panel (Acute Lymphoblastic Leukemia) |
| Price (AED) | 2,000 |
| Turnaround Time | 10 calendar days |
| Sample Type / Matrix | Bone Marrow Aspirate (preferred) or Peripheral Blood |
| Methodology Used | Interphase Fluorescence In‑Situ Hybridization (FISH) |
| ICD-10-CM Code | C91.0 |
| LOINC Code | 100358-2 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians